Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Middeldorp

Showing results (151-160 of 342) with videos related to

Pageof 35
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 2, 2013
Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regressionStefanie Hillebrand, Karin B Gast, Renée de Mutsert, et al.
Lupus|August 17, 2024
Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controlsValérie Lbi Jansen, Mark Davids, Dagmar Jm van Mourik, et al.
Blood|July 3, 2009
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic familiesWillem M Lijfering, Nic J G M Veeger, Saskia Middeldorp, et al.
Blood|June 11, 2011
Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraceptionElizabeth F W van Vlijmen, Nic J G M Veeger, Saskia Middeldorp, et al.
Thrombosis Research|July 19, 2020
Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitorsLuis Jara-Palomares, Aurora Solier-López, Mariaconcetta Russo, et al.
Thrombosis and Haemostasis|July 8, 2016
Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reportingJan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
Blood Advances|February 11, 2021
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasmsEva N Hamulyák, Joost G Daams, Frank W G Leebeek, et al.
The New England Journal of Medicine|September 24, 2010
Fondaparinux for the treatment of superficial-vein thrombosis in the legsHervé Decousus, Paolo Prandoni, Patrick Mismetti, et al.
Hypertension (Dallas, Tex. : 1979)|January 14, 2020
Hypertensive Complications of Pregnancy and Risk of Venous ThromboembolismLuuk J J Scheres, Willem M Lijfering, Norbert F M Groenewegen, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and HaemostasisMaha Othman, Amparo Santamaría Ortiz, María Cerdá, et al.
Pageof 35

Showing results (151-160 of 342) with videos related to

Sort By:
Pageof 35
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 2, 2013
Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regressionStefanie Hillebrand, Karin B Gast, Renée de Mutsert, et al.
Lupus|August 17, 2024
Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controlsValérie Lbi Jansen, Mark Davids, Dagmar Jm van Mourik, et al.
Blood|July 3, 2009
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic familiesWillem M Lijfering, Nic J G M Veeger, Saskia Middeldorp, et al.
Blood|June 11, 2011
Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraceptionElizabeth F W van Vlijmen, Nic J G M Veeger, Saskia Middeldorp, et al.
Thrombosis Research|July 19, 2020
Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitorsLuis Jara-Palomares, Aurora Solier-López, Mariaconcetta Russo, et al.
Thrombosis and Haemostasis|July 8, 2016
Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reportingJan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
Blood Advances|February 11, 2021
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasmsEva N Hamulyák, Joost G Daams, Frank W G Leebeek, et al.
The New England Journal of Medicine|September 24, 2010
Fondaparinux for the treatment of superficial-vein thrombosis in the legsHervé Decousus, Paolo Prandoni, Patrick Mismetti, et al.
Hypertension (Dallas, Tex. : 1979)|January 14, 2020
Hypertensive Complications of Pregnancy and Risk of Venous ThromboembolismLuuk J J Scheres, Willem M Lijfering, Norbert F M Groenewegen, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and HaemostasisMaha Othman, Amparo Santamaría Ortiz, María Cerdá, et al.
Pageof 35